Kidney Injury Molecule-1 Is Associated with Contrast-Induced Nephropathy in Elderly Patients with Non-STEMI

Mustafa Ahmet Huyut1

  • 1Yeni Yuzyil University, Faculdade de Medicina, Departamento de Cardiologia, Istambul - Turquia.

Insights

Serum kidney injury molecule-1 (KIM-1) and Mehran score predict contrast-induced nephropathy (CIN) in elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI). Higher KIM-1 levels correlate with increased risk of major adverse cardiovascular events (MACE) post-procedure.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Contrast-induced nephropathy (CIN) is linked to major adverse cardiovascular events (MACE).
  • Oxidative stress mechanisms are implicated in the development of CIN.

Purpose of the Study:

  • To investigate the association between serum kidney injury molecule-1 (KIM-1) levels and CIN.
  • To evaluate CIN predictors in elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI).

Main Methods:

  • A cohort of 758 NSTEMI patients undergoing percutaneous coronary intervention (PCI) was studied.
  • 15 patients developed CIN, compared to a matched control group of 104.
  • Serum KIM-1, Mehran score, and clinical outcomes were assessed at baseline and up to 72 hours, with one-year follow-up.

Main Results:

  • CIN occurred in 12.60% of patients.
  • Serum KIM-1 and Mehran scores were significantly higher in the CIN group (p < 0.001 and p = 0.001, respectively).
  • Major adverse cardiovascular events (MACE) were significantly more frequent in the CIN group (46.70% vs. 11.50%, p = 0.001).

Conclusions:

  • Baseline serum KIM-1 concentration and Mehran score are independent predictors of CIN in elderly NSTEMI patients.
  • The CIN group experienced significantly higher rates of mortality, cardiovascular death, myocardial reinfarction, stroke, and MACE at one-year follow-up.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
127
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
250
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
497
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
400
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
430
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
112